Companies / Hummingbird Bioscience
Hummingbird Bioscience
Singapore, Singapore
Hummingbird Bioscience is developing a pipeline of next-generation antibody-based therapeutics, including ADCs, for patients who do not respond to current treatments.
Hummingbird Bioscience, based in Singapore, Singapore, has 7 investors on file, among them Altium Capital, ClavystBio and Decheng Capital. Its site was last checked 13 Nov 2026: site answers.
Investors
7 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Hummingbird Bioscience and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Altium Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/hummingbirdbioscience.com/investors
# also
GET /v1/companies/hummingbirdbioscience.com
GET /v1/companies/hummingbirdbioscience.com/news